Financial Performance - Revenues for the six months ended June 30, 2024, increased to 1,368,000comparedto977,000 for the same period in 2023, representing a growth of 40%[21] - Gross profit for the three months ended June 30, 2024, was 514,000,asignificantimprovementfromalossof103,000 in the same period of 2023[21] - The net loss for the six months ended June 30, 2024, was 5,344,000,comparedtoanetlossof5,562,000 for the same period in 2023, indicating a reduction in losses[21] - For the six months ended June 30, 2024, the net loss was 5,344,000,aslightimprovementfromanetlossof5,562,000 in the same period of 2023, representing a 3.9% decrease in losses[30] - Total revenues for the six months ended June 30, 2024, were 1.368million,a40977 thousand in the same period of 2023[63] - Product revenues during the six months ended June 30, 2024, amounted to 1.157million,up51766 thousand in the prior year[63] Expenses and Costs - Research and development expenses for the six months ended June 30, 2024, were 2,975,000,slightlyhigherthan2,753,000 in the same period of 2023[21] - Total stock-based payment expenses for the six months ended June 30, 2024, were 963thousand,comparedto685 thousand in the same period of 2023, reflecting an increase of 41%[62] - The company expects to continue incurring significant research and development costs, necessitating additional funding to sustain operations until profitability is achieved[36] Cash Flow and Assets - Cash and cash equivalents increased to 13,238,000asofJune30,2024,from8,945,000 as of December 31, 2023, representing a growth of approximately 48%[15] - Net cash flows used in operating activities for the six months ended June 30, 2024, were 3,323,000,comparedto5,083,000 in the same period of 2023, indicating a 34.6% reduction in cash outflow[30] - The company reported a significant increase in cash flows from investing activities, with net cash flows provided amounting to 7,970,000forthesixmonthsendedJune30,2024,comparedtoacashoutflowof15,557,000 in the same period of 2023[30] - Total current assets decreased to 15,406,000asofJune30,2024,downfrom19,349,000 as of December 31, 2023, reflecting a decline of approximately 20%[15] - The company’s cash and cash equivalents at the beginning of the period were 8,945,000,downfrom10,099,000 in the previous year[30] Liabilities and Equity - Total liabilities increased slightly to 5,148,000asofJune30,2024,comparedto5,022,000 as of December 31, 2023[18] - Shareholders' equity decreased to 13,426,000asofJune30,2024,downfrom17,807,000 as of December 31, 2023, a decline of approximately 25%[18] - As of June 30, 2024, the company had accumulated a deficit of approximately 39.5millionsinceitsincorporation[36]StockandShares−Thecompanyreportedaweightedaverageof10,447,000ordinarysharesforthesixmonthsendedJune30,2024,comparedto8,864,000forthesameperiodin2023[21]−Thecompanygranted91,000stockoptionsduringthesixmonthsendedJune30,2024,withafairvaluecostestimatedatapproximately435 thousand[57] - The company had outstanding warrants to purchase 5,763,273 shares of common stock as of June 30, 2024[50] - The company issued 2,144,583 shares of Common Stock at a price of 4.80pershare,raisingapproximately10.3 million in the 2024 Private Placement[72][73] Inventory and Assets Management - Inventory as of June 30, 2024, totaled 439thousand,adecreasefrom504 thousand at the end of 2023[67] - As of June 30, 2024, the company's contract fulfillment assets were 1.136million,downfrom1.256 million at the end of 2023[64] - The total remaining performance obligations (RPO) as of June 30, 2024, amounted to 2.2million,expectedtoberecognizedovertheproduct′smanufacturingterm[66]LeaseandOperatingActivities−Right−of−useassetsobtainedinexchangeforoperatingleaseliabilitiesamountedto120,000 for the six months ended June 30, 2024, compared to 465,000inthesameperiodof2023[32]−Thecompanyhasaweightedaverageremainingleasetermof0.86yearsforitsoperatingleasesasofJune30,2024[46]−MonthlyleasepaymentsfortheoriginalofficespaceinOmer,Israel,areapproximately7,000, while payments for the Ramat Gan office space are about $25,000[45] Development and Future Outlook - The company has been approved by the Israel Innovation Authority to enhance its production line and capabilities over the next 24 months, with a royalty obligation of 3% on the funding received[71] - The company has no assurance that forward-looking statements will occur due to various risks and uncertainties associated with its business[10]